Why is Fredun Pharma falling/rising?

As of 25-Jul, Fredun Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at 910.00, which reflects a decrease of 9.0 or 0.98%. The stock has underperformed its sector today by 1.15%, and while it is trading above its 20-day, 50-day, 100-day, and 200-day moving averages, it is below its 5-day moving average. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 67.17% against the 5-day average. Despite a strong long-term growth outlook, with net sales and operating profit showing impressive annual growth rates, the stock's recent performance has been impacted by these short-term factors. In the broader market context, the stock's performance over the past week shows a slight decline of 0.22%, while the benchmark Sensex has decreased by 0.36%. Over the past month, Fredun Pharmaceuticals has outperformed the benchmark with a return of 11.93% compared to the Sensex's -1.56%. Despite the recent price drop, the company has demonstrated healthy long-term growth, with a return of 10.04% over the past year, significantly higher than the market's negative return of -0.19%. This indicates that while the stock is facing short-term challenges, its overall performance remains strong relative to the market.